Showing results (1-10 of 403) with videos related to
Sort By:
Pageof 41
Pediatric Pulmonology|March 19, 2025
Global Representation Matters: Publishing Innovations to Support Authors From Less Resourced EnvironmentsSusanna A McColleyExpert Opinion on Drug Safety|March 12, 2016
A safety evaluation of ivacaftor for the treatment of cystic fibrosisSusanna A McColleyThe Lancet. Respiratory Medicine|May 9, 2021
Long-term safety of lumacaftor-ivacaftor in children aged 2-5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, extension studyJordana E Hoppe, Mark Chilvers, Felix Ratjen, et al.Pediatric Pulmonology|September 9, 2015
2014 year in review: Cystic fibrosisAdrienne P Savant, Susanna A McColleyPediatric Pulmonology|June 14, 2017
Cystic fibrosis year in review 2016Adrienne P Savant, Susanna A McColleyPediatric Pulmonology|June 22, 2018
Cystic fibrosis year in review 2017Adrienne P Savant, Susanna A McColleyPediatric Pulmonology|January 20, 2021
Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotypeMeghan E McGarry, Susanna A McColleyPediatric Pulmonology|November 19, 2020
Cystic fibrosis year in review 2019: Section 3 multisystem-based care and researchAdrienne P Savant, Susanna A McColleyPediatric Pulmonology|May 13, 2016
Pediatric Pulmonology year in review 2015: Part 4Adrienne P Savant, Susanna A McColleyPediatric Pulmonology|March 3, 2011
Elevated vascular endothelial growth factor is correlated with elevated erythropoietin in stable, young cystic fibrosis patientsKimberly Danieli Watts, Susanna A McColleyPageof 41